What Gridinsoft observed on Polarbiopeptides.com
A Gridinsoft threat analyst reviewed the site directly and documented the evidence behind this decision.
GMA-20260901200808-7e7c5d40
- Reviewed
- by Gridinsoft Threat Analyst
- Analyst finding
- Suspicious Shop
- Evidence basis
- First-party site analysis External vendor intelligence: Context only — not used for this decision
Retain Suspicious Shop. This result is based on reproducible first-party observations: the checkout methods materially differ from the payment branding; research-only language conflicts with human, clinical, and bodybuilding marketing; public batch certificates cannot be independently verified or tied to current sellable lots; and live subordinate hosts inside the parent namespace serve unrelated high-risk commerce and shipping surfaces. No specific malware payload, phishing credential flow, malicious download, or harmful exact URL was reproduced, so external domain-blacklist labels are recorded separately as reputation context rather than sample-level proof.
Analyst findings
Review 8 documented observations View evidence
Seventeen current public pages were reviewed across the storefront, company information, FAQ, policies, contact, certificates, cart, checkout, product listings, and an editorial article. The site exposed 117 product listings and normal same-site navigation. Repeated requests did not reproduce an automatic executable download, an unrelated redirect from the apex, a credential-theft flow, or a malware payload.
-
HTTP status
200 -
Final URL
https://polarbiopeptides.com/ - Page element Current title: Polar Biopeptides | Polar Bio-Peptides.
- Page element The current storefront exposed 117 product listings.
- Analyst observation No automatic executable download, unrelated apex redirect, impersonated login, credential receiver, malware file, payload, command, exploit, or hash was identified in the reviewed public scope.
The FAQ says products are for research use and not for human use, but the same storefront directly markets human and clinical effects. Current pages offered Semaglutide 10mg, Botolinum Toxin 100ui, and Aqualyx for immediate cart addition; described Aqualyx as fat-dissolving injections for clinical use; and addressed athletes, bodybuilders, and fitness enthusiasts in an article about peptide effects.
- Page element The FAQ states that all products are strictly intended for research purposes only and are not approved for human use.
- Page element The Semaglutide 10mg listing offered 10 vials per kit for $65 with an Add to cart action.
- Page element The Botolinum Toxin 100ui listing offered one vial per kit for $28 with an Add to cart action.
- Page element The Aqualyx listing described fat-dissolving injections for clinical use and licensed practitioners and offered a 10-vial pack for $110.
- Page element The current bodybuilding article addresses athletes, bodybuilders, and fitness enthusiasts and describes recovery, muscle, fat-loss, and performance effects.
The public footer and payment presentation displayed Visa, PayPal, Stripe, Mastercard, and cash-on-delivery branding. After a Semaglutide product was placed in a temporary cart, the live checkout instead offered only cryptocurrency, direct bank transfer, Chime, and Zelle. No order was placed and no payment was submitted.
- Page element The public site displayed Visa, PayPal, Stripe, Mastercard, and Cash On Delivery payment branding.
- Page element The live checkout offered Pay with Crypto, Direct bank transfer, Pay with Chime, and Pay with Zelle.
- Analyst observation A Semaglutide product was added to a temporary cart only to expose the checkout options; no order or payment was submitted.
The site says every batch is tested by an independent third-party laboratory, but the public certificate page exposed 26 image certificates for a storefront with 117 product listings. The sampled images contained product and batch labels and HPLC-style purity fields, but no live independent-laboratory verification URL or externally checkable report identifier was shown, and the product pages did not visibly map the currently offered lot to a certificate.
- Public artifact URL https://polarbiopeptides.com/certificate-of-analysis/
- Page element The certificate page displayed 26 certificate images while the current storefront exposed 117 product listings.
- Page element Sampled images included product names, batch labels, purity values, and HPLC-style fields.
- Analyst observation The reviewed public artifacts did not expose a live independent-laboratory verification URL, an externally checkable report identifier, or a visible mapping from the currently offered product lot to a certificate.
Certificate-transparency records exposed subordinate hostnames below polarbiopeptides.com. One exact subordinate host resolved to the same IP address and served a separate storefront titled Psychedelics Arena; another resolved to the same IP address and redirected to a separate shipping-and-tracking site. These are live objects inside the submitted parent namespace, not merely unrelated sites on shared hosting.
- DNS fact polarbiopeptides.com, psychedelicstrippyarena.com.polarbiopeptides.com, and roadwayexpressshipping.com.polarbiopeptides.com resolved to 198.251.89.144 during review.
-
Final URL
https://psychedelicstrippyarena.com.polarbiopeptides.com/ - Page element The subordinate host returned HTTP 200 with the title Home | Psychedelics Arena and promoted psychedelic products.
-
Redirect destination
https://roadwayexpressshipping.com/ - Analyst observation The roadwayexpressshipping.com.polarbiopeptides.com subordinate host redirected to a separate worldwide shipping and tracking site.
The submitted host is the registrable parent domain, and www was checked separately. urlscan returned one public apex scan from May 15, 2026 that ended on a hosting human-verification page and supplied no malicious verdict; www had no result. OTX exposed one generic domain-category pulse and ten URL observations without a Google Safe Browsing match. No available Wayback or Arquivo snapshot was found. Authorization-only URLhaus and ThreatFox APIs and unavailable Common Crawl were treated as unknown, not clean.
- Public artifact URL https://urlscan.io/result/019e2ab3-ab50-774c-9f13-c2ef357b110e/
- Public artifact URL https://otx.alienvault.com/indicator/domain/polarbiopeptides.com
- Public artifact URL https://web.archive.org/web/*/https://polarbiopeptides.com/
- Analyst observation urlscan returned one historical apex scan and zero www scans; the recorded apex scan ended on a human-verification page and did not publish a malicious verdict.
- Analyst observation OTX associated the apex with one generic Phishing & scam domain names pulse and exposed eight apex plus two www URL observations with no Google Safe Browsing match in those records.
- Analyst observation No available Wayback or Arquivo snapshot was found; URLhaus and ThreatFox required authorization and Common Crawl was unavailable, so those gaps were not counted as clean results.
A fresh supported Gridinsoft rescan reached the current site and retained the Suspicious Shop classification. Its current VirusTotal snapshot contained 52 harmless, zero malicious, one suspicious, and 37 undetected engines; the sole suspicious entry was a domain-level SOCRadar blacklist label. Separate Bitdefender, Avira, and Norton checks were clean or not found. No provider supplied a concrete harmful object in the available result.
- Public artifact URL https://gridinsoft.com/online-virus-scanner/url/polarbiopeptides-com
- Page element Fresh VirusTotal snapshot: 52 harmless, 0 malicious, 1 suspicious, and 37 undetected engines.
- Analyst observation The one suspicious VirusTotal entry was a domain-level SOCRadar blacklist result; no malware file, payload, credential receiver, exact harmful URL, or hash accompanied it.
- Analyst observation The fresh direct Bitdefender, Avira, and Norton checks were clean or not found.
The apex and www resolved to 198.251.89.144, and www redirected to the HTTPS apex. The active certificate covered the apex and wildcard subdomains. RDAP recorded creation on May 15, 2026. Valid TLS and stable resolution support current operation but do not validate the merchant, products, laboratory claims, or fulfillment.
- DNS fact Apex and www A: 198.251.89.144.
-
Redirect destination
https://polarbiopeptides.com/ - Certificate fact The active certificate covered polarbiopeptides.com and *.polarbiopeptides.com.
- Analyst observation RDAP recorded domain creation on May 15, 2026.
Scope and limitations
- The result applies to the public apex, www, reviewed pages, cart and checkout surface, and certificate-discovered subordinate hosts at the recorded time. No purchase, payment, injection, laboratory test, or physical fulfillment test was performed.
- The certificate images were assessed only as public artifacts. The review did not authenticate their issuer, test a product batch, or determine that a document was genuine or false.
- Authenticated administration, server-side files, private communications, order records, payment accounts, and hosting logs were not available for review.
- Public search indexes, threat feeds, sandboxes, and web archives are incomplete. Unavailable or authorization-only sources were treated as unknown, and a newly supplied exact URL, file, hash, redirect, order record, or laboratory verification should be reviewed as a separate object.
Help protect others by sharing this page on social media! The more people who know about polarbiopeptides.com, the fewer chances they have to deceive someone else. Help others evaluate polarbiopeptides.com by sharing this page on social media!